5.63 USD
↘ 0.10 (1.66%)LIVE (AS OF 02:48 PM EDT)
Lexeo Therapeutics, Inc. Common Stock
LXEONASDAQ • USD
Market: OPEN
Open?$5.73
High?$6.00
Low?$5.53
Prev. Close?$5.72
Volume?4.9M
Avg. Volume?878.0K
VWAP?$5.97
Rel. Volume?5.56x
Bid / Ask
Bid?$5.56 × 100
Ask?$5.58 × 100
Spread?$0.02
Midpoint?$5.57
Valuation & Ratios
Market Cap?423.8M
Shares Out?74.1M
Float?62.8M
Float %?86.1%
P/E Ratio?N/A
P/B Ratio?1.72
EPS?-$1.35
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?11.21Strong
Quick Ratio?11.21Strong
Cash Ratio?3.75Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?1.72CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.3CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-40.5%WEAK▾
ROA?-37.2%WEAK▾
Cash Flow & Enterprise
FCF?$-98958000
Enterprise Value?$361.6M
Related Companies
Loading...
News
Profile
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
Employees
59
Market Cap
423.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2023-11-03
Address
345 PARK AVENUE SOUTH
NEW YORK, NY 10010
Phone: (212) 547-9879
NEW YORK, NY 10010
Phone: (212) 547-9879